Description

Justification for Direct Award The Blood Bank is expanding its operations into new facilities and requires four new plasmapheresis instruments that must operate seamlessly with the existing ISO-certified solution based on Fresenius Kabi equipment integrated via DXT and ProSang. To the best of our knowledge, no other plasmapheresis instruments on the market today are technically compatible with the established middleware or capable of integrating directly with ProSang without development of a new integration solution. Operation of parallel systems is considered unacceptable due to increased risk, complexity, training needs, and significant additional operational and quality-related costs. Full replacement of the current equipment is also not feasible, as the existing machines have substantial remaining service life and represent major investments. See the attached document for a detailed justification. Based on this, it is assessed that only Fresenius Kabi Norway AS can supply plasmapheresis equipment that meets the Blood Bank’s technical requirements. Four (4) Aurora plasmapheresis instruments from Fresenius Kabi AS will therefore be procured. The conditions for a direct award without competition under FOA § 13-4 (2) are considered fulfilled. Competition is impossible for technical reasons. Any objections must be submitted to the project manager within 10 days after publication of the notice.

Afficher la description complète

Source officielle

Source : TED - Tenders Electronic Daily (Publications Office of the EU)

Vérifiez toujours les détails dans l'avis officiel.

Dernière vérification auprès de TED - Tenders Electronic Daily (Publications Office of the EU) il y a 1 mois

Consulter l'avis officiel

Plus de cet acheteur

Profil complet de l'acheteur

1 marché ouvert actuellement

78129 RH KLM IMM Instrument de production pour thérapie cellulaire 26 oct. 2026 27 jours restants

Attributions récentes

Norvege - Equipements de laboratoire, d'optique et de precision (sauf lunettes) - 78045 E2026 RA KRE KRF Cytometre en flux
attribué à Matriks AS 789 449 €
Norvege - Equipements medicaux, produits pharmaceutiques et produits de soins personnels - 77203 RH KLM PAT Immune colour machines V3
attribué à AGILENT DGG NORGE AS; Roche Diagnostics Norge AS 25 127 966 €
Laboratory, optical and precision equipments (excl. glasses) - 78102 RA KRE KRF Automatic electrophores instruments for RNA and DNA (2 items)
attribué à Matriks AS 1 020 976 €